Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$40.65 - $59.54 $1.67 Million - $2.45 Million
41,107 Added 26.26%
197,626 $9.29 Million
Q1 2023

May 15, 2023

BUY
$37.27 - $46.57 $15,727 - $19,652
422 Added 0.27%
156,519 $6.57 Million
Q4 2022

Feb 14, 2023

SELL
$32.2 - $43.61 $12,268 - $16,615
-381 Reduced 0.24%
156,097 $5.95 Million
Q3 2022

Nov 14, 2022

BUY
$32.28 - $43.27 $43,900 - $58,847
1,360 Added 0.88%
156,478 $6.13 Million
Q2 2022

Aug 15, 2022

BUY
$27.52 - $37.99 $82,972 - $114,539
3,015 Added 1.98%
155,118 $5.01 Million
Q1 2022

May 16, 2022

BUY
$30.71 - $45.71 $37,036 - $55,126
1,206 Added 0.8%
152,103 $5.04 Million
Q4 2021

Feb 14, 2022

SELL
$37.06 - $47.11 $385,164 - $489,614
-10,393 Reduced 6.44%
150,897 $6.42 Million
Q3 2021

Nov 15, 2021

BUY
$40.26 - $57.37 $3,422 - $4,876
85 Added 0.05%
161,290 $7.15 Million
Q2 2021

Aug 16, 2021

BUY
$54.88 - $79.29 $7,902 - $11,417
144 Added 0.09%
161,205 $9.16 Million
Q1 2021

May 17, 2021

BUY
$70.65 - $96.76 $18,086 - $24,770
256 Added 0.16%
161,061 $12.1 Million
Q4 2020

Feb 16, 2021

BUY
$58.41 - $89.06 $206,479 - $314,827
3,535 Added 2.25%
160,805 $13.9 Million
Q3 2020

Nov 16, 2020

BUY
$41.13 - $62.45 $3.57 Million - $5.43 Million
86,887 Added 123.45%
157,270 $9.61 Million
Q2 2020

Aug 14, 2020

BUY
$25.95 - $43.15 $403,756 - $671,370
15,559 Added 28.38%
70,383 $2.93 Million
Q1 2020

May 14, 2020

SELL
$26.15 - $77.24 $334,432 - $987,822
-12,789 Reduced 18.92%
54,824 $1.57 Million
Q4 2019

Feb 13, 2020

BUY
$60.18 - $154.77 $3.23 Million - $8.3 Million
53,603 Added 382.61%
67,613 $4.88 Million
Q3 2019

Nov 14, 2019

BUY
$140.29 - $189.96 $15,011 - $20,325
107 Added 0.77%
14,010 $1.97 Million
Q2 2019

Aug 13, 2019

SELL
$157.85 - $183.09 $7,261 - $8,422
-46 Reduced 0.33%
13,903 $2.55 Million
Q1 2019

May 15, 2019

BUY
$89.33 - $163.65 $181,607 - $332,700
2,033 Added 17.06%
13,949 $2.22 Million
Q4 2018

Feb 13, 2019

BUY
$81.94 - $139.71 $263,519 - $449,307
3,216 Added 36.97%
11,916 $1.14 Million
Q2 2018

Aug 14, 2018

BUY
$140.36 - $175.76 $1.22 Million - $1.53 Million
8,700 New
8,700 $1.36 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Aristotle Atlantic Partners, LLC Portfolio

Follow Aristotle Atlantic Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Atlantic Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Atlantic Partners, LLC with notifications on news.